CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Large Increase in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 20,400 shares, an increase of 19.3% from the September 30th total of 17,100 shares. Based on an average daily volume of 31,700 shares, the days-to-cover ratio is presently 0.6 days.

CERo Therapeutics Price Performance

CEROW remained flat at $0.01 during trading on Wednesday. The company’s stock had a trading volume of 11,530 shares, compared to its average volume of 44,700. CERo Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25. The company’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.03.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.